Vesigen Therapeutics
Business Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1 Kendall Sq Ste 1 Bldg 200, Cambridge, ...Phone Number
(617) 633-7188Website
www.vesigentx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Vesigen Therapeutics
Vesigen Therapeutics is a biotechnology company advancing groundbreaking therapies directed to intracellular targets using a fusogenic extracellular vesicle delivery technology. The company's patented technology, called ARMMs (ARRDC1 Mediated Microvesicles), is expanding the universe of druggable targets by enabling the delivery of a wide range of payloads, including RNAs (mRNA, shRNA, ribozymes), proteins (signaling proteins, enzymes, antibody fragments), and gene-editing complexes (Cas9/gRNA) directly into the cytoplasm of target cells. The team is committed to leveraging ARMMs technology to develop transformative medicines and address currently unmet medical needs.Explore more
Vesigen Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Vesigen Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Vesigen Therapeutics is spiking on competitors!
Check if Vesigen Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Vesigen Therapeutics launches new products
Funding: Get notified immidiatlly once Vesigen Therapeutics has new funding data
Vesigen Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Vesigen Therapeutics had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Vesigen Therapeutics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Vesigen Therapeutics
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Vesigen Therapeutics
Compare insights from companies similar to Vesigen Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Vesigen Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Vesigen Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Vesigen Therapeutics.
Vesigen Therapeutics Tech Stack
A closer look at the technologies used by Vesigen Therapeutics
Most Recent Scoops
Event
Events
Facilities Relocation / Expansion
Vesigen Therapeutics is planning to move offices in September 2023. The move will impact employees at the existing office located at 790 Memorial Drive, Suite #103, Cambridge, MA.
Executive Move
Board of Directors
New Hire
Executive Move
Thomas Bordner has joined the organization as Senior Director Intellectual Property & Chief Patent Counsel.
Executive Moves, New Hire
New Hire
Executive Move
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Vesigen Therapeutics
Sign Up For FreeTo access detailed company insights
Vesigen Therapeutics is a biotechnology company advancing groundbreaking therapies directed to intracellular targets using a fusogenic extracellular vesicle delivery technology. The company's patented technology, called ARMMs (ARRDC1 Mediated Microvesicles), is expanding the universe of druggable targets by enabling the delivery of a wide range of... Read More
